Catalyst Pharmaceuticals Inc (STU:CN2)
€ 27.5 (0%) Market Cap: 3.38 Bil Enterprise Value: 2.72 Bil PE Ratio: 18.10 PB Ratio: 3.80 GF Score: 70/100

Catalyst Pharmaceuticals Inc Extraordinary Shareholders Meeting Transcript

Jul 08, 2026 / 01:00PM GMT
Release Date Price: €27.5
Unidentified Company Representative

Good morning, and welcome to the Special Meeting of Stockholders of Catalyst Pharmaceuticals, Inc. Before we get started, I would like to go over a few items, so you know how to participate in today's meeting. You have joined the Special Stockholders' Meeting using your computer's speaker system by default. (Event Instructions) Please note that no one attending this meeting via the virtual meeting platform is permitted to use any audio or video recording devices.

I would now like to introduce Patrick J. McEnany, the Chairman of the Board of Directors of Catalyst Pharmaceuticals, Inc., who will preside over today's meeting.

Patrick McEnany
Catalyst Pharmaceuticals Inc - Non-Executive Chairman of the Board

Good morning, and welcome to the Special Meeting of the Stockholders of Catalyst Pharmaceuticals, Inc. I am Patrick McEnany, the Chairman of Catalyst's Board of Directors. The Board of Directors has authorized that I preside over this meeting as Chairperson. Pursuant to Catalyst's Certificate of Incorporation and bylaws, the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot